Skip to main content

Table 1 Baseline characteristics of patients

From: Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis

 

PRGF

BM-MSCs + PRGF

N

26

24

Age (range)

54.6 (33,70)

56 (40, 62)

Males, n (%)

16 (61.54)

17 (29.17)

BMI (kg/m2)

25.3 (23.1, 28.7)

27 (25.2, 29.3)

K-L 2, n (%)

8 (30.77)

5 (20.83)

K-L 3, n (%)

5 (19.23)

2 (20)

K-L 4, n (%)

13 (50)

12 (50)

  1. Unless specified, data are presented as mean. OA, osteoarthritis; K–L, Kellgren and Lawrence grading scale of severity of knee OA
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us